Overview

Effect of Intravenous Lidocaine, Used to Attenuate Pain With Propofol Injection, on Defibrillation Threshold Testing

Status:
Terminated
Trial end date:
2010-05-01
Target enrollment:
Participant gender:
Summary
The use of lidocaine, as an anesthetic drug, during implantation of an implantable cardioverter-defibrillator(ICD)will not result in a clinically significant alteration of the defibrillation threshold during ICD placement.
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
Drexel University College of Medicine
Treatments:
Lidocaine
Propofol